The cost-effectiveness analysis of the New Rural Cooperative Medical Scheme in China.

<h4>Objective</h4>The New Rural Cooperative Medical Scheme (NCMS) is a universal healthcare coverage plan now covering over 98% of rural residents in China, first implemented in 2003. Rising costs in the face of modest gains in health and financial protections have raised questions about...

Full description

Bibliographic Details
Main Authors: Jinjing Wu, Shelby Deaton, Boshen Jiao, Zohn Rosen, Peter A Muennig
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0208297
id doaj-1c1a34529f0a497eb76f01f7e729062b
record_format Article
spelling doaj-1c1a34529f0a497eb76f01f7e729062b2021-03-04T10:39:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011312e020829710.1371/journal.pone.0208297The cost-effectiveness analysis of the New Rural Cooperative Medical Scheme in China.Jinjing WuShelby DeatonBoshen JiaoZohn RosenPeter A Muennig<h4>Objective</h4>The New Rural Cooperative Medical Scheme (NCMS) is a universal healthcare coverage plan now covering over 98% of rural residents in China, first implemented in 2003. Rising costs in the face of modest gains in health and financial protections have raised questions about the cost-effectiveness of the NCMS.<h4>Methods</h4>Using the most recent estimates of the NCMS's health and economic consequences from a comprehensive review of the literature, we conducted a cost-effectiveness analysis using a Markov model for a hypothetical cohort between ages 20 and 100. We then did one-way sensitivity analyses and a probabilistic sensitivity analysis using Monte Carlo simulations to explore whether the incremental cost-effectiveness ratio (ICER) falls below 37,059 international dollars [Int$], the willingness-to-pay (WTP) threshold of three times per capita GDP of China in 2013.<h4>Findings</h4>The ICER of the NCMS over the lifetime of an average 20-year-old rural resident in China was about Int$71,480 per quality-adjusted life year (QALY) gained (95% confidence interval: cost-saving, Int$845,659/QALY). There was less than a 33% chance that the system was cost-saving or met the WTP threshold. However, the NCMS did fall under the threshold when changes in the program costs, the risk of mortality and hypertension, and the likelihood of labor force participation were tested in one-way sensitivity analyses.<h4>Conclusion</h4>The NCMS appears to be economically inefficient in its current form. Further cost-effectiveness analyses are warranted in designing insurance benefit packages to ensure that the NCMS fund goes toward health care that has a good value in improving survival and quality of life.https://doi.org/10.1371/journal.pone.0208297
collection DOAJ
language English
format Article
sources DOAJ
author Jinjing Wu
Shelby Deaton
Boshen Jiao
Zohn Rosen
Peter A Muennig
spellingShingle Jinjing Wu
Shelby Deaton
Boshen Jiao
Zohn Rosen
Peter A Muennig
The cost-effectiveness analysis of the New Rural Cooperative Medical Scheme in China.
PLoS ONE
author_facet Jinjing Wu
Shelby Deaton
Boshen Jiao
Zohn Rosen
Peter A Muennig
author_sort Jinjing Wu
title The cost-effectiveness analysis of the New Rural Cooperative Medical Scheme in China.
title_short The cost-effectiveness analysis of the New Rural Cooperative Medical Scheme in China.
title_full The cost-effectiveness analysis of the New Rural Cooperative Medical Scheme in China.
title_fullStr The cost-effectiveness analysis of the New Rural Cooperative Medical Scheme in China.
title_full_unstemmed The cost-effectiveness analysis of the New Rural Cooperative Medical Scheme in China.
title_sort cost-effectiveness analysis of the new rural cooperative medical scheme in china.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2018-01-01
description <h4>Objective</h4>The New Rural Cooperative Medical Scheme (NCMS) is a universal healthcare coverage plan now covering over 98% of rural residents in China, first implemented in 2003. Rising costs in the face of modest gains in health and financial protections have raised questions about the cost-effectiveness of the NCMS.<h4>Methods</h4>Using the most recent estimates of the NCMS's health and economic consequences from a comprehensive review of the literature, we conducted a cost-effectiveness analysis using a Markov model for a hypothetical cohort between ages 20 and 100. We then did one-way sensitivity analyses and a probabilistic sensitivity analysis using Monte Carlo simulations to explore whether the incremental cost-effectiveness ratio (ICER) falls below 37,059 international dollars [Int$], the willingness-to-pay (WTP) threshold of three times per capita GDP of China in 2013.<h4>Findings</h4>The ICER of the NCMS over the lifetime of an average 20-year-old rural resident in China was about Int$71,480 per quality-adjusted life year (QALY) gained (95% confidence interval: cost-saving, Int$845,659/QALY). There was less than a 33% chance that the system was cost-saving or met the WTP threshold. However, the NCMS did fall under the threshold when changes in the program costs, the risk of mortality and hypertension, and the likelihood of labor force participation were tested in one-way sensitivity analyses.<h4>Conclusion</h4>The NCMS appears to be economically inefficient in its current form. Further cost-effectiveness analyses are warranted in designing insurance benefit packages to ensure that the NCMS fund goes toward health care that has a good value in improving survival and quality of life.
url https://doi.org/10.1371/journal.pone.0208297
work_keys_str_mv AT jinjingwu thecosteffectivenessanalysisofthenewruralcooperativemedicalschemeinchina
AT shelbydeaton thecosteffectivenessanalysisofthenewruralcooperativemedicalschemeinchina
AT boshenjiao thecosteffectivenessanalysisofthenewruralcooperativemedicalschemeinchina
AT zohnrosen thecosteffectivenessanalysisofthenewruralcooperativemedicalschemeinchina
AT peteramuennig thecosteffectivenessanalysisofthenewruralcooperativemedicalschemeinchina
AT jinjingwu costeffectivenessanalysisofthenewruralcooperativemedicalschemeinchina
AT shelbydeaton costeffectivenessanalysisofthenewruralcooperativemedicalschemeinchina
AT boshenjiao costeffectivenessanalysisofthenewruralcooperativemedicalschemeinchina
AT zohnrosen costeffectivenessanalysisofthenewruralcooperativemedicalschemeinchina
AT peteramuennig costeffectivenessanalysisofthenewruralcooperativemedicalschemeinchina
_version_ 1714804962995732480